| Days after submission:||8
|Vaccination / Manufacturer
||Lot / Dose
||Site / Route|
|MMR: MEASLES + MUMPS + RUBELLA (MMR II) / MERCK & CO. INC.
||1342S / UNK
||- / -
Administered by: Private Purchased by: Private
Hepatic function abnormal,
SMQs:, Liver related investigations, signs and symptoms (narrow), Severe cutaneous adverse reactions (broad), Anaphylactic reaction (narrow), Acute pancreatitis (broad), Haemorrhage terms (excl laboratory terms) (narrow), Neuroleptic malignant syndrome (broad), Systemic lupus erythematosus (broad), Anticholinergic syndrome (broad), Pseudomembranous colitis (broad), Oropharyngeal conditions (excl neoplasms, infections and allergies) (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Conjunctival disorders (narrow), Ocular infections (broad), Hypersensitivity (narrow), Noninfectious diarrhoea (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? Yes, 2 days
Extended hospital stay? No
Previous Vaccinations: ~ ()~~~In patient
Other Medications: Seldane in the summer
Preexisting Conditions: Hayfever, sinus problems
Diagnostic Lab Data: SGOT elevated at 125, SPGT elevated at 137, LDH elevated at 527 CPK elevated at 808. Urinalysis showed .1% glucose & trace protein.
CDC Split Type:
Write-up: Febrile exanthem; 4 days prior to admission nausea, vomiting & diarrhea. 1 day prior to admission generalized erythematous rash beginning on extremities & progressing to trunk; Epistaxis & rhinorrhea w/mild cough. Febrile to 101.9; Conjuct.